OMC
OMGA

Oasis Management Company’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Oasis Management Company’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-160,000
Closed -$914K – 116
2022
Q4 		$914K Hold
160,000
– – 0.18% 50
2022
Q3 		$867K Hold
160,000
– – 0.15% 63
2022
Q2 		$608K Buy
+160,000
New +$596K 0.11% 78

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Oasis Management Company's OMGA Position: Q1 2023 in Review

Oasis Management Company sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q1 2023, closing a stake of 160,000 shares — an estimated $914K sold.

Oasis Management Company first reported a position in OMGA in Q2 2022 and held it in 3 quarters. The position peaked at $914K in Q4 2022. 54 funds tracked by Wall St. Rank hold OMGA as of Q1 2023.

  • Oasis Management Company reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Oasis Management Company sold 160,000 Omega Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $914K.
  • Oasis Management Company first reported a position in Omega Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Oasis Management Company's Omega Therapeutics, Inc. Common Stock position peaked at $914K in Q4 2022.
  • 54 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Oasis Management Company's 13F filing for Q1 2023, filed 15 May 2023.